Filing Flows

Filing Flows › Clover Health Investments (CLOV) › Q1 2026

Clover Health Investments (CLOV) Q1 2026 earnings results (first quarter 2026)

10-Q filed May 8, 2026

Clover Health Investments (CLOV) reported revenue of $749M for the first quarter 2026 (Q1 2026), +62% from a year earlier and +54% from the quarter before. Operating margin was 3.6%, net earnings $27.3M (3.6% of revenue).

Revenue$749M
Year over year+62%
Quarter over quarter+54%
Operating margin3.6%
Net earnings$27.3M

Clover Health Investments, Q1 2026: revenue $749M (+62% year over year), operating margin 3.6%, net earnings $27.3M, operating cash flow $108M. The chart follows the revenue to costs, profit and cash.

Q1 2026AmountQ/QY/Y
Revenue$749M+54%+62%
Operating profit$27.3M——
Net earnings$27.3M——
Operating cash flow$108M——
Free cash flow$107M——

What changed

Revenue was $749.2M in Q1 2026, up 62% year over year and up 54% from the previous quarter.

Operating profit was $27.3M, a 3.6% margin (up 3.9 points year over year). Total costs grew 56% against revenue growth of 62%. The fastest-growing cost line was Other operating costs (+57%). Net earnings were $27.3M. The effective tax rate was 0.0%.

Operating cash flow was $107.9M, 395% of net earnings. Non-cash charges added back $12.3M of share-based compensation. Working capital and other items added $68.3M. Capital expenditures of $854K left free cash flow of $107.0M.

Questions

What was Clover Health Investments' revenue in the first quarter 2026?

Clover Health Investments (CLOV) reported revenue of $749M for the first quarter 2026 (Q1 2026), +62% from a year earlier and +54% from the quarter before.

Was Clover Health Investments profitable in the first quarter 2026?

Operating profit was $27.3M (3.6% of revenue) and net earnings $27.3M.

Open the interactive Sankey →

Source: Clover Health Investments 10-Q on SEC EDGAR.